MINNEAPOLIS, June 17, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), today announced a series of corporate updates following the closing of all its previously-announced definitive merger agreements, which transformed the Company into one of the largest U.S. multi-state cannabis operators and expanded the Company’s portfolio to six states with active operations. The Company announced that it expects pro forma revenue and adjusted EBITDA for the second quarter ...

Paul Joachimczyk Sonoco Names Paul Joachimczyk Chief Financial Officer HARTSVILLE, S.C., June 17, 2025 (GLOBE NEWSWIRE) -- Sonoco Products Company (NYSE: SON), a global leader in value-added sustainable packaging, today announced that Paul Joachimczyk has been named Chief Financial Officer, effective June 30, 2025. “We are pleased to have Paul joining the Sonoco family. He is a highly accomplished financial executive with a proven track record of successfully leading financial functions for large multi ...

High-volume asset gives Company a foothold in one of the strongest performing retail corridors in the trade area Acquisition positions Whitestone to benefit from upcoming development, driven by strong neighborhood dynamics HOUSTON, June 17, 2025 (GLOBE NEWSWIRE) -- Whitestone REIT (NYSE: WSR), a neighborhood-focused owner and operator of open-air shopping centers in Texas and Arizona, today announced it has acquired 5000 South Hulen, a 86,907 square-foot shopping center located in Fort Worth, Texas. 5000 S ...

TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- STORAGEVAULT CANADA INC. (“StorageVault” or the “Corporation”) (SVI-TSX announced today that a quarterly dividend of $0.002961 per common share (“Common Share”) ‎will be payable on ‎July 15, 2025 to shareholders of record on June 30, 2025, with an ex-dividend ‎date of June 30, 2025. This dividend has been designated as an “eligible dividend” for Canadian ‎income tax ‎purposes.‎ ‎ About StorageVault Canada Inc.As of March 31, 2025, StorageVault owned and operated 25 ...

EDMONTON, Alberta, June 17, 2025 (GLOBE NEWSWIRE) -- Regenx Tech Corp., (the "Company" or "Regenx") (CSE: RGX) (OTCQB: RGXTF) (FSE: YRS WKN: A2DSW3) is providing an update on the status of the restart of operations at its new facility in Newport, Tennessee. The restart of operations has been delayed awaiting the issuing of the Air Pollution Control Construction permit from the Tennessee Department of Environment and Conversation. The permits were initially applied for on December 18, 2024, and the departmen ...

Dr. Pruthi brings vast clinical development experience advancing novel therapies for NMIBC to Relmada and the NDV-01 program Phase 3 trial for NDV-01 expected to begin in H1 2026 CORAL GABLES, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system indications, today announced the appointment of Raj S. Pruthi, MD as Chief Medical Officer-Urology ...

MONTREAL, June 17, 2025 (GLOBE NEWSWIRE) -- SRQ Resources Inc. (“SRQ” or the “Company”) (TSX-V: SRQ) is pleased to announce the mobilization of drilling crews and the commencement of its 4,000-metre diamond drilling program at the highly prospective Target 900 located on the Lac Brulé property, under Autorisation d’Exploration à Impact ATI-118, in the Province of Québec, Canada. “We’re excited to kick off drilling at Target 900—an important milestone in revealing the potential of Lac Brulé,” said Dr. Marc-A ...

Shares Expected to Begin Trading on Split-Adjusted Basis on June 20, 2025LOS ALTOS, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (NASDAQ: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that it will implement a 1-for-10 reverse split of the issued shares of its common stock, effective at 4:01 p.m. Eastern Time on June 18, 2025. The Company's common stock is expected to begin trading on a split-adjusted basis when ...

CORAL GABLES, Fla., June 17, 2025 /PRNewswire/ -- MasTec, Inc. (NYSE: MTZ) today announced that Paul DiMarco, its Executive Vice President and CFO, will be participating in a fireside chat with our covering analyst at the J.P. Morgan 2025 Energy, Power, Renewables & Mining Investor Conference on Tuesday, June 24th at approximately 10:55 a.m. Eastern Time. Additionally, one-on-one meetings with institutional investors and MasTec's senior management are also being arranged as a part of the conference.The audi ...

Core Viewpoint - Albion Technology & General VCT PLC reported a positive interim management statement for the period from January 1, 2025, to March 31, 2025, highlighting an increase in net asset value and successful fundraising efforts [2][3][4]. Performance - The unaudited net asset value (NAV) as of March 31, 2025, was £274.8 million, equating to 73.51 pence per share, reflecting an increase of 0.47 pence per share (0.6%) since December 31, 2024 [3]. Fundraising - A Top Up Offer for new ordinary shares commenced on January 6, 2025, reaching its £30 million limit by March 31, 2025, which included a £10 million over-allotment facility [4]. - On March 21, 2025, the company issued 29,774,402 shares at an issue price ranging from 74.54 to 75.30 pence, resulting in net consideration of £21,748,000 [4]. Portfolio - New investments during the period totaled £2,670,000, with notable allocations including: - Latent Technology Group: £1,722,000 in reinforcement learning-based animation - Innerworks Technology: £350,000 in adaptive security - Scripta Therapeutics: £274,000 in AI-enabled drug discovery [5]. - Further investments amounted to £2,590,000, with significant contributions to: - Mondra Global: £1,273,000 in food supply chain emissions modeling - TransFICC: £1,097,000 in connectivity solutions for financial institutions [5]. Top Holdings - As of March 31, 2025, the top ten holdings included: - Quantexa: £51,401,000 (18.7% of NAV) focused on network analytics for financial crime detection - Proveca: £18,414,000 (6.7% of NAV) specializing in reformulating medicines for children [6][7]. Share Buy-backs - The company did not conduct any share buy-backs during the period due to being in a close period until April 23, 2025, but maintains a policy to buy back shares at around a 5% discount to NAV when market conditions allow [8][9]. Material Events Post-Period - After the period ended, on April 4, 2025, the company issued 10,100,775 new ordinary shares at an issue price of 75.30 pence, generating net consideration of £7,378,000 [10].